Normunity Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$75M
- Investors
-
11
Normunity General Information
Description
Operator of a biotechnology company intended to create precision immuno-oncology medicines. The company's medicine drives the exclusion of T-cells from immune-sensitive tumors and other mechanisms that are barriers to normal immune function, enabling doctors to treat cancer by restoring the state of normal immunity.
Contact Information
Website
www.normunity.comCorporate Office
- 101 College Street
- New Haven, CT 06510
- United States
Corporate Office
- 101 College Street
- New Haven, CT 06510
- United States
Normunity Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 24-Sep-2025 | $75M | Completed | Clinical Trials - Phase 1 | ||
| 2. Early Stage VC (Series A) | 25-Oct-2022 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 11-Jan-2022 | $42.1M | $42.1M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Normunity Comparisons
Industry
Financing
Details
Normunity Competitors (17)
One of Normunity’s 17 competitors is Enterome, a Venture Capital-Backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Enterome | Venture Capital-Backed | Paris, France | ||||
| Eligo Bioscience | Venture Capital-Backed | Paris, France | ||||
| Vedanta Biosciences | Venture Capital-Backed | Cambridge, MA | ||||
| 4D pharma | Corporation | Leeds, United Kingdom | ||||
| Seres Therapeutics | Formerly VC-backed | Cambridge, MA |
Normunity Patents
Normunity Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026090139-A1 | Anti-ly6k antibody-drug conjugates and methods of use | Pending | 21-Oct-2024 | ||
| WO-2026039453-A1 | Anti-klk6 antibodies and methods of use | Pending | 12-Aug-2024 | ||
| EP-4820379-A2 | Anti-ly6k antibodies and methods of use | Pending | 04-Dec-2023 | ||
| WO-2025122587-A2 | Anti-ly6k antibodies and methods of use | Inactive | 04-Dec-2023 | ||
| WO-2025122587-A3 | Anti-ly6k antibodies and methods of use | Inactive | 04-Dec-2023 | C07K16/28 |
Normunity Signals
Normunity Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Enavate Sciences | Venture Capital | Minority | ||
| HSG (Hong Kong) | Venture Capital | Minority | ||
| Pfizer Ventures | Corporate Venture Capital | Minority | ||
| Regeneron Ventures | Corporate Venture Capital | Minority | ||
| Samsara BioCapital | Venture Capital | Minority |
Normunity FAQs
-
When was Normunity founded?
Normunity was founded in 2020.
-
Where is Normunity headquartered?
Normunity is headquartered in New Haven, CT.
-
What is the size of Normunity?
Normunity has 23 total employees.
-
What industry is Normunity in?
Normunity’s primary industry is Drug Discovery.
-
Is Normunity a private or public company?
Normunity is a Private company.
-
What is Normunity’s current revenue?
The current revenue for Normunity is .
-
How much funding has Normunity raised over time?
Normunity has raised $182M.
-
Who are Normunity’s investors?
Enavate Sciences, HSG (Hong Kong), Pfizer Ventures, Regeneron Ventures, and Samsara BioCapital are 5 of 11 investors who have invested in Normunity.
-
Who are Normunity’s competitors?
Enterome, Eligo Bioscience, Vedanta Biosciences, 4D pharma, and Seres Therapeutics are some of the 17 competitors of Normunity.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process